pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Jul 23·1 min read
save

Nordic biotech must unite to become a global force, say venture investors

Jul 23, 2026·read at BioSpace ↗Neutral

The latest episode of BioSpace's podcast Denatured features Ester Sklarsky of Sound Bioventures and João Ribas of Novo Holdings Seed Investments discussing the future of Nordic biotech.

The guests note that the region, particularly Norway and Finland, remains fragmented and that a more coordinated approach will be needed for its companies to compete on a global scale.

They argue that aligning investment strategies and fostering cross-border collaboration could transform the Nordic ecosystem into a stronger international player.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Nordic biotech’s next act: From fragmentation to global force”

read at BioSpace ↗
284 words · retrieved Jul 23
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVO5

related stories

  • May 6STAT+: Oregon hospitals won’t outsource to national physician chain after allSTAT
  • May 6STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’STAT
  • May 6Novo hikes guidance on Wegovy pill’s fast sales startBioPharma Dive
  • May 6STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human diseaseSTAT
  • May 6STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share priceSTAT